ROBERT SIEGEL, host: In 2004, Merck pulled its painkiller Vioxx from the market. The drug was causing heart problems, strokes and deaths among patients in a large study that was under way at the time.

This study was designed to confirm or refute the associations found in our previous panel study using a more robust design that included more subjects as well as making indoor and outdoor measurements ...

In a recent study published in The Lancet, researchers performed an implementation study of a 12-gene pharmacogenetic panel across seven European countries to investigate whether a gene-drug ...

A new study suggests the standard panel size for primary care physicians, about 2,500 patients, is “neither accurate nor reasonable.” For the study, published in the Journal of the American Board of ...

NEW DELHI: The Ministry of Education has constituted a nine-member panel to review concerns related to private coaching institutions, rise of ‘dummy schools’, and the effectiveness and fairness of ...